icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Cannabis Research Efforts Progressing Despite Federal Tax and Banking Regulations

By Michael Harlow and Craig Golding Partners at CohnReznick There are some unique challenges to conducting research in the United States on the medical applications of cannabis. Cannabis’ federal Schedule I classification presents several obstacles for cannabis industry operators and businesses, even for those located in states where medical and recreational use is legal. Strict [...]
Read more

Federal Restrictions on Cannabis Still a Hurdle to Understanding the Plant’s Genome – But There is Good News

By Tracy Curley, Partner at Cohnreznick The legal status of cannabis presents a challenge toward advancements in quality assurance and medical research. Currently, the Controlled Substance Act carries no distinction between the medical and recreational uses of cannabis, which is classified as a Schedule I drug – meaning a substance or chemical defined by the […]
Read more

States Challenged to Optimize Cannabis Tax Revenues

Some reinventing the cannabis tax-reform wheel as they go along By Bob Moss, Principal, National Director of Governmental Affairs & Eddie Delgado, CMI, Cohn Reznick For the states with cannabis initiatives on the ballot this fall, there is a fine line between passing legislation and being prepared to implement the new law. With time and more […]
Read more

Cannabis Legalization in New York: What the State’s New Study is Missing

By Noah Potter, Esquire, Of Counsel to Hoban Law Group [Editor’s note: This is the second of a two-part review regarding the status of adult-use legalization in New York State in light of the governor’s commissioned report by the Department of Health. The first segment ran in this space yesterday.]  On July 13, the New […]
Read more

Cannabis Legalization in New York: A Question of When and How, Not Whether

By Noah Potter, Esquire, Of Counsel to Hoban Law Group [Editor’s note: This is the first of a two-part review regarding the status of adult-use legalization in New York State in light of the governor’s commissioned report by the Department of Health. The second segment will run in this space tomorrow.]  On July 13, the […]
Read more

The Fight for Weed

By Bob Moss, Principal, National Director of Governmental Affairs for Cohn Reznick For those of you that remember the 1971 top pop song, “I Feel the Earth Move” by Carole King, it was also in 1971 that President Nixon announced the War on Drugs, which classified marijuana as a Schedule 1 drug. Forty seven years […]
Read more

CBD Impact on Healthcare

  Wholesale prices in maturing U.S. adult-use cannabis markets keep declining, with the Average Market Rate (AMR) in Colorado falling to $1,012, half that of 2014’s market launch. AMR, which sets growers’ excise tax liability, varies across markets: In Nevada, the average flower rate is $2,268, more than 2x that of Colorado’s, while other markets […]
Read more

Colorado’s Cannabis Wholesale Price Trends

  Wholesale prices in maturing U.S. adult-use cannabis markets keep declining, with the Average Market Rate (AMR) in Colorado falling to $1,012, half that of 2014’s market launch. AMR, which sets growers’ excise tax liability, varies across markets: In Nevada, the average flower rate is $2,268, more than 2x that of Colorado’s, while other markets […]
Read more

U.S. Federal Cannabis Legalization = 1.04 Million Jobs

  New Frontier Data’s latest report, Cannabis in the U.S. Economy, shows that under full legalization, the retail operations sector would have the most jobs (364k), followed by administrative (229k) and manufacturing (166k) While these percentages were applied on a national scale, percentage breakdowns by sector will vary by region, dependent upon local rules and […]
Read more

Federal Cannabis Revenue to Total $44B Through 2025

  As retail revenue continues to grow in legal cannabis, so will jobs, business opportunities, payroll and of course tax revenue produced for the federal government. Total federal tax revenue is estimated $2.9 billion for 2017. Tax revenue is expected to grow consistently reaching $6.7 billion by 2025. Roughly 200,000 jobs exist in today’s legal cannabis market. By […]
Read more
Top